Endonovo Therapeutics, Inc. (ENDV) financial statements (2020 and earlier)

Company profile

Business Address 6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments53799056411
Cash and cash equivalents53799056411
Receivables113    
Other current assets    3362
Other undisclosed current assets23 21247  
Total current assets:393821113033783
Noncurrent Assets
Property, plant and equipment771163243
Intangible assets, net (including goodwill)3,3683,8534,500   
Intangible assets, net (excluding goodwill)3,3683,8534,500   
Total noncurrent assets:3,3753,8604,501163243
TOTAL ASSETS:3,4144,2424,61231940946
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,4749432,7144,7383,9903,167
Accounts payable346157    
Accrued liabilities 786    
Interest and dividends payable1,128     
Other undisclosed accounts payable and accrued liabilities  2,7144,7383,9903,167
Debt6,9386,054412121,097
Deferred compensation liability2,3872,246   1,525
Derivative instruments and hedges, liabilities7,0674,4265,9401,9283,974 
Due to related parties195270206245291
Other undisclosed current liabilities1,7631,5394,7312,0371,265(1,525)
Total current liabilities:19,82515,47913,4098,7219,4864,555
Noncurrent Liabilities
Long-term debt and lease obligation 322241729
Long-term debt, excluding current maturities 322241729
Other undisclosed noncurrent liabilities155123731155183155
Total noncurrent liabilities:155155753159199184
Total liabilities:19,98015,63414,1638,8819,6854,739
Temporary equity, carrying amount1,7631,539598   
Stockholders' equity
Stockholders' equity attributable to parent, including:(16,566)(11,392)(9,550)(8,562)(9,276)(4,693)
Preferred stock000   
Common stock83433213108
Common stock, share subscribed but unissued, subscriptions receivable(2)(2)   (2)
Common stock, value, subscriptions  (2)(2)(2) 
Additional paid in capital30,62224,18719,6049,8013,7741,593
Deferred compensation equity(1,000)     
Accumulated deficit(47,270)(35,620)(29,184)(18,374)(13,059)(6,293)
Other undisclosed stockholders' equity attributable to parent1,0000    
Other undisclosed stockholders' equity(1,763)(1,539)(598)   
Total stockholders' equity:(18,329)(12,931)(10,148)(8,562)(9,276)(4,693)
TOTAL LIABILITIES AND EQUITY:3,4144,2424,61231940946

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues20483  424
Revenue, net  424
Cost of revenue(54)(13)  (2)(15)
Cost of goods and services sold    (2)(15)
Gross profit:15070  29
Operating expenses(4,261)(4,230)(4,604)(5,411)(2,567)(2,200)
Other operating expense, net
(Other Expenses)
     (3)
Other undisclosed operating income     3
Operating loss:(4,111)(4,159)(4,604)(5,411)(2,565)(2,191)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(6,157)(2,277)(6,206)95(4,201)1,411
Interest and debt expense273172,485(488)(128)(1,411)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(27)(317)(2,485)4881281,232
Net loss available to common stockholders, diluted:(10,268)(6,436)(10,810)(5,316)(6,766)(959)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(10,268)(6,436)(10,810)(5,316)(6,766)(959)
Comprehensive loss, net of tax, attributable to parent:(10,268)(6,436)(10,810)(5,316)(6,766)(959)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: